At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 194 enrolled
Drug / intervention
Imedeen +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomized, Double-blind, Placebo Controlled Trial Assessing The Effects Of An Oral Dietary Supplement Containing Marine And Plant Extracts On Overall Facial Skin Appearance Among Healthy Adult Women With Photo-aged Skin
In Brief
A Phase 4 clinical trial evaluating Imedeen and Placebo for Photodamaged Skin. Completed, enrolled 194 participants across 4 sites.
Detailed Summary
The study hypothesis is that Imedeen will show effects on skin health, when compared to placebo over a 6 month intervention period with respect to changes in skin appearance, skin density, moisture, and in fine lines and wrinkles.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPhotodamaged Skin
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2013
First PostedFeb 2013
Primary CompletionMar 2014
TodayJul 2026
First PostedFeb 8, 2013
Enrollment StartJan 1, 2013
Primary CompletionMar 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 13.4 years ago
Interventions
Imedeendietary
Two tablets per day for 6 months
Placebodietary
Two tablets per day for 6 months